barriers to conducting clinical trials

R&D

Take the hybrid road to bring clinical trials to patients

As the landscape of clinical trials evolves, decentralised clinical trials (DCTs) have emerged to put patients at the centre of the research process.

R&D

Science 37 UCB pharma virtual clinical trials

Focus on the positive to stop public perception being a barr...

Public misconceptions surrounding the process, its risks and its benefits remain a significant barrier to clinical trial participation, which is not surprising in a world where the only int

Oncology

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

barriers to conducting clinical trials

Editor's Picks